Overview
- Visa agreed to acquire Israeli behavioral biometrics firm BioCatch for $2.4 billion in cash in a deal announced Monday, August 3, 2026, that will buy shares from Permira-advised funds and other holders.
- BioCatch analyzes thousands of anonymized session signals such as keystrokes, swipe and touch patterns, and device handling to spot account takeovers and coached fraud in real time and says it protects roughly 760 million users across 1.8 billion devices and more than 350 banks.
- The purchase is subject to regulatory approval and customary closing conditions and Visa expects to complete the integration by the end of its fiscal second quarter of 2027 with BioCatch’s leadership remaining in place.
- Visa framed the deal as a response to a surge in AI-enabled scams, noting losses from account takeovers exceed $1 trillion annually, and the acquisition follows a wider industry trend of card networks buying specialized security firms.
- If integrated across Visa’s network, BioCatch’s real-time signals could give banks and merchants earlier fraud alerts and reduce customer harm, though the companies will need to navigate regulator scrutiny and technical work to scale the technology across Visa’s global rails.